G Wang,Y Yu,C Sun,T Liu,T Liang,L Zhan,X Lin and X-H Feng*.STAT3 selectively interacts with Smad3 to antagonize TGF-β.Oncogene advance online publication 30 November 2015;doi: 10.1038/onc.2015.446December 01,2015

编辑: Date:2015/12/01

Oncogene advance online publication 30 November 2015; doi: 10.1038/onc.2015.446

Gaohang Wang, Yi Yu, Chuang Sun, Ting Liu, Tingbo Liang, Lixing Zhan,  Xia Lin and Xin-Hua Feng*

Abstract

Smad and STAT proteins are critical signal transducers and transcription factors in controlling cell growth and tumorigenesis. Here we report that the STAT3 signaling pathway attenuates transforming growth factor-β (TGF-β)-induced responses through a direct Smad3–STAT3 interplay. Activated STAT3 blunts TGF-β-mediated signaling. Depletion of STAT3 promotes TGF-β-mediated transcriptional and physiological responses, including cell cycle arrest, apoptosis and epithelial-to-mesenchymal transition. STAT3 directly interacts with Smad3 in vivo and in vitro, resulting in attenuation of the Smad3–Smad4 complex formation and suppression of DNA-binding ability of Smad3. The N-terminal region of DNA-binding domain of STAT3 is responsible for the STAT3–Smad3 interaction and also indispensable for STAT3-mediated inhibition of TGF-β signaling. Thus, our finding illustrates a direct crosstalk between the STAT3 and Smad3 signaling pathways that may contribute to tumor development and inflammation.